EXHIBIT 10.3
WAFERGEN
BIO-SYSTEMS, INC.
PUT OPTION
AGREEMENT
THIS PUT OPTION
AGREEMENT (this “
Agreement ”) is entered into as of May
28, 2008, by
and among (i) Alnoor Shivji (the “ Founder ”),
the founder and chairman, chief
executive
officer and president of WaferGen Bio-systems, Inc., a Nevada
corporation
(“
WaferGen US ”), and (ii) Malaysian Technology
Development Corporation Sdn Bhd (the
“
Investor ”), a purchaser of Series A Redeemable
Convertible Preference Shares (“ Series A
Shares ”) issued by WaferGen Biosystems (M) Sdn.
Bhd. (formerly known as Global Dupleks
Sdn. Bhd.), a
Malaysian corporation (the “ Company ”),
pursuant to that certain Share
Subscription
and Shareholders Agreement dated as of the date hereof (the “
Purchase
Agreement ”) between WaferGen US, the Investor and
the Company.
RECITALS
A. WHEREAS, the
Investor has entered into the Purchase Agreement for the
purchase and
subscription of certain Series A Shares of the Company.
B. WHEREAS, in
order to induce the Investor to enter into the Purchase
Agreement,
the Founder has
agreed to grant to the Investor an option to put (the “
Put Right ”) to the Founder
the Series A
Shares purchased by the Investor pursuant to the Purchase Agreement
upon the
occurrence of a
Triggering Event, as such term is defined below.
NOW, THEREFORE, in
consideration of the mutual promises, representations,
warranties,
covenants and conditions set forth in this Agreement, the parties
mutually agree as
follows:
AGREEMENT
SECTION
1
PUT
OPTION
1.1 Grant of Put
Option. Upon receipt by the Investor of written notice by
the
Founder of a
Triggering Event, the Investor shall have the option (the “
Put Option ”) to require
the Founder to
purchase from the Investor, subject to the conditions set forth in
this Agreement,
all of the
Series A Shares initially purchased by the Investor pursuant to the
Purchase Agreement
or the number
of Series A Shares then held by the Investor, whichever is less, at
a per share
purchase price
equal to US$2.25 (the “ Put Option Price ”). In
order to exercise such Put Option,
the Investor
must deliver written notice to the Founder of the Investor’s
election to exercise the
Put Option in
accordance with Section 1.3 of this Agreement within 15 days of the
date on which
the Investor
receives written notice of the Triggering Event from the
Founder.
1.2 Notice of
Triggering Event. The Founder shall provide the Investor written
notice
of a Triggering
Event within seven days of the date on which the Triggering Event
occurs. A
“
Triggering Event ” shall occur when the Founder sells
or transfers, prior to May 15, 2009, in
one or more
transactions, greater than 2,185,960 shares of Common Stock of
WaferGen US
(which amount
equals approximately 80% of the shares of Common Stock of WaferGen
US
owned by the
Founder on the date hereof) to one or more Third Parties (the
“ Put Shares ”).
“
Third Party ” means any person or entity other than
the Founder’s Affiliates (as defined
below), or the
relatives (by blood or marriage) of the Founder or the
Founder’s Affiliates;
provided,
however, that in the event of any transfer or sale of any Put
Shares by the Founder to
the
Founder’s Affiliates or the relatives of the Founder or the
Founder’s Affiliates (such person
or entity, a
“ Transferee ”), such Transferee shall agree in
writing to be bound by the terms of this
Agreement with
respect to such Put Shares. “ Affiliate ” means,
with respect to a person or entity,
any other
person or entity directly or indirectly controlling, controlled by,
or under common
control with
such person or entity.
1.3 Manner of
Exercise. The Investor shall exercise the Put Option by giving
an
irrevocable
written notice to the Founder, within 15 days of the date on which
the Investor
receives
written notice of the Triggering Event from the Founder, that the
Investor elects to
exercise such
Put Option upon the terms and subject to the conditions set forth
in this
Agreement.
1.4 Closing and
Payment. The closing of the purchase and sale of the Put
Shares
shall occur on
the date designated in writing by the Founder to the Investor,
which date shall be
within 120 days
following the date upon which the Founder received the written
notice from the
Investor that
the Investor was electing to exercise the Put Option. The aggregate
Put Option
Price shall be
payable to the Investor by the Founder by wire transfer of
immediately available
funds on the
closing date to an account designated in writing by the Investor or
by delivery of a
certified or
cashiers’ check by the Founder to the Investor, in each case
against the Founder’s
receipt of the
Investor’s share certificates of the Put Shares and share
transfer forms duly
executed by the
Investor for the transfer of the Put Shares to the Founder or any
other nominee of
the
Founder.
1.5 Rights After
Closing. From and after the closing of the purchase of the
Put
Shares by the
Founder, all rights of the Investor with respect to the Put Shares
shall cease, and
such shares
shall be owned legally and beneficially by the Founder for all
purposes and will be
transferred to
the Founder on the books and records of the Company.
1.6 Partial
Purchase. The Founder shall not be obligated to purchase the Put
Shares if
the Founder
shall be unable to do so without a breach or violation of the
provisions of applicable
law or the
certificate of incorporation or bylaws of WaferGen US as in effect
on such date. If the
Founder is
unable to purchase all of the Put Shares